Hrt Financial LP Mustang Bio, Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.35 - $0.72 $1,918 - $3,946	5,481 Added 53.51%	15,723 $5,000
Q4 2022 Feb 10, 2023	SELL	$0.32 - $0.52 $703 - $1,142	-2,197 Reduced 17.66%	10,242 $4,000
Q3 2022 Nov 14, 2022	BUY	$0.46 - $0.76 $408 - $675	889 Added 7.7%	12,439 $5,000
Q2 2022 Aug 12, 2022	BUY	$0.58 - $1.13 $6,698 - $13,051	11,550 New	11,550 $6,000
Q1 2021 May 17, 2021	SELL	$3.02 - $5.16 $46,202 - $78,942	-15,299 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$2.66 - $4.18 $40,695 - $63,949	15,299 New	15,299 $57,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $46.3M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.